News for 'drug supply'

NVIDIA CEO: AI Driving Trillion-Dollar Infrastructure Boom and Blue-Collar Job Creation

NVIDIA CEO: AI Driving Trillion-Dollar Infrastructure Boom and Blue-Collar Job Creation

Rediff.com11 Mar 2026

NVIDIA CEO Jensen Huang argues that Artificial Intelligence is driving the largest infrastructure buildout in human history, requiring trillions of dollars in investment and creating significant demand for skilled blue-collar labour.

Nagaland Govt to Form Interim Council for Frontier Nagaland Territorial Authority

Nagaland Govt to Form Interim Council for Frontier Nagaland Territorial Authority

Rediff.com2 Mar 2026

Nagaland Governor Ajay Kumar Bhalla announced the state government's plans to form an interim council for the Frontier Nagaland Territorial Authority (FNTA) and highlighted key achievements and future priorities across various sectors during the Budget Session.

If Iran, Why Not Pakistan, Mr Trump?

If Iran, Why Not Pakistan, Mr Trump?

Rediff.com18 Mar 2026

If the Iranian regime needs to be punished for promoting quasi-terrorist outfits like Hezbollah and Hamas, then what about Pakistan which has spent decades exporting terror around the world, killing thousands, particularly in Afghanistan and India? asks M R Narayan Swamy.

Multinational pharma cos, Indian drugmakers diverge to mutual gain: How win-win is it?

Multinational pharma cos, Indian drugmakers diverge to mutual gain: How win-win is it?

Rediff.com11 Mar 2026

For decades, multinational pharmaceutical companies and Indian drugmakers worked in ways that supported each other: MNCs brought innovation and brands, while Indian companies built scale through generics and cost efficiency. There was an important overlap - generic drugs - but this is shrinking fast. And the consequences are reshaping India's gigantic pharmaceutical market.

Weight Loss Drug Mounjaro Registers Rs 80 Cr Sales

Weight Loss Drug Mounjaro Registers Rs 80 Cr Sales

Rediff.com8 Oct 2025

The bumper rise is due to the rising demand for the drug and patients' gradual shift towards its higher dosage.

TN special teams to monitor drug firms after cough syrup deaths

TN special teams to monitor drug firms after cough syrup deaths

Rediff.com17 Oct 2025

Tamil Nadu has formed special teams to monitor drug manufacturers after deaths of infants in Madhya Pradesh were linked to a cough syrup made by a Tamil Nadu-based company. Inspections are being conducted at pharmaceutical firms across the state.

Indian pharma companies see sharp drop in adverse USFDA findings in 2025

Indian pharma companies see sharp drop in adverse USFDA findings in 2025

Rediff.com8 Jan 2026

The US Food and Drug Administration (USFDA) recorded a significant decline in serious regulatory findings at Indian drug manufacturing facilities between January and December 2025. Data reveals that 'official action indicated' (OAI) cases - the most severe classification - nearly halved over the past year.

'Venezuela's Current Leaders Gave Maduro As A Trophy To Trump'

'Venezuela's Current Leaders Gave Maduro As A Trophy To Trump'

Rediff.com8 Jan 2026

'Trump had done a deal with the current regime minus Maduro. The current regime is giving Trump entry into Venezuelan oil. They are obeying him and doing whatever he says.' 'They are happy because they have saved their heads by sacrificing only two, Maduro and his wife. Thousands of Venezuelan military leaders would have been jailed or killed in American action had Maduro stayed in power.'

AI ecosystem opaque, needs accountability: CCI chairperson

AI ecosystem opaque, needs accountability: CCI chairperson

Rediff.com26 Feb 2026

The artificial intelligence (AI) ecosystem is opaque and needs to be made transparent and accountable, said Competition Commission of India's (CCI) Chairperson Ravneet Kaur at the Business Standard Manthan Summit on Wednesday.

Indian pharma to get stronger dose of EU mkt access

Indian pharma to get stronger dose of EU mkt access

Rediff.com5 Feb 2026

The European Union's (EU's) offer to slash tariffs on 97.5 per cent of Indian chemical exports to zero is set to give India's pharmaceutical and medical device firms preferential access to the European markets.

Healthcare Funds: Caution Advised

Healthcare Funds: Caution Advised

Rediff.com12 Feb 2026

Most first-time investors may be better served by diversified options such as flexicap or multi-cap funds, which already hold pharma and healthcare stocks.

India launches nationwide HPV vaccination drive

India launches nationwide HPV vaccination drive

Rediff.com24 Feb 2026

The Indian government is set to launch a nationwide HPV vaccination program targeting 14-year-old girls to prevent cervical cancer, utilizing a single-dose vaccine and aiming for equitable access across socio-economic groups.

Dr Reddy's profit down 14% on low Lenalidomide US sales

Dr Reddy's profit down 14% on low Lenalidomide US sales

Rediff.com22 Jan 2026

Pharma major Dr Reddy's Laboratories (DRL) reported a 14 per cent year-on-year (Y-o-Y) drop in consolidated net profit to Rs 1,210 crore in the December quarter of FY 2025-26 (Q3FY26) on low sales of cancer drug Lenalidomide in the North American market. The firm's revenue from operations grew to Rs 8,727 crore in Q3FY26, a 4.4 per cent Y-o-Y increase from Rs 8,357 crore recorded for the same quarter last year.

GST cut on drugs, medical devices to help patients

GST cut on drugs, medical devices to help patients

Rediff.com4 Sep 2025

The government's move to cut GST on medicines and medical devices while exempting lifesaving drugs from the levy is a bold step that will bring direct relief to patients and families while significantly reducing financial strain on them, pharmaceuticals and healthcare industry players said on Thursday.

Trump's Huge Venezuela Gamble

Trump's Huge Venezuela Gamble

Rediff.com24 Jan 2026

I am inclined to believe that the Venezuela adventure is not an indication of American strength, alas, but rather of American weakness, points out Rajeev Srinivasan.

Indian Pharma Majors Ready With Weight Loss Drugs

Indian Pharma Majors Ready With Weight Loss Drugs

Rediff.com12 Aug 2025

Prices for Indian consumers are expected to come down significantly from the current Rs 17,000-Rs 26,000 monthly.

3 patients die at Punjab hospital, kin blame O2 supply fault

3 patients die at Punjab hospital, kin blame O2 supply fault

Rediff.com28 Jul 2025

Among the patients, one was hospitalised with snake bite, the second was a drug overdose patient, while the third was suffering from tuberculosis. All three were put on ventilators.

UP cracks down on illegal cough syrup trade, 75 arrested

UP cracks down on illegal cough syrup trade, 75 arrested

Rediff.com20 Dec 2025

Uttar Pradesh authorities have registered 74 cases and arrested 75 people in connection with the illegal storage and sale of codeine-based cough syrup. A minister alleges links to the Samajwadi Party and an SIT is investigating.

Over 50 held as T'gana's EAGLE Force hits Nigerian cartel's India Ops

Over 50 held as T'gana's EAGLE Force hits Nigerian cartel's India Ops

Rediff.com29 Nov 2025

Telangana's anti-narcotics wing, the EAGLE Force, conducted a multi-state operation against a Nigerian drug cartel, resulting in over 50 arrests and the seizure of narcotics worth Rs 3.5 crore.

Union Budget 2026: Sitharaman tries to cover all bases, leaves out markets

Union Budget 2026: Sitharaman tries to cover all bases, leaves out markets

Rediff.com1 Feb 2026

Budget 2026 sticks to fiscal discipline, shuns populist measures despite five key state elections coming up, but ends up rattling stock markets with a higher transaction tax on derivatives trading.

Ozempic launched in India, priced at Rs 2,200 per week

Ozempic launched in India, priced at Rs 2,200 per week

Rediff.com12 Dec 2025

Danish pharma major Novo Nordisk on Friday launched its blockbuster type 2 diabetes treatment injection Ozempic, globally popular for its weight-loss benefits.

Shimla police bust 500-member online drug trafficking network

Shimla police bust 500-member online drug trafficking network

Rediff.com30 Jan 2025

An extensive drug trafficking network operating throughout north India, with a particular focus on Shimla, has been busted following the arrest of two individuals - one from Kolkata and one from Delhi. The syndicate used online platforms for booking drugs, misusing innocent people's accounts and delivering drugs through couriers. Police have frozen 21 accounts associated with the network and arrested 16 individuals, including the kingpin, Sandeep Shah.

A long-game Budget

A long-game Budget

Rediff.com2 Feb 2026

The Union Budget for 2026-27, presented by Finance Minister (FM) Nirmala Sitharaman on Sunday, which was a first, had an excellent domestic macro backdrop. According to the first advance estimates, gross domestic product (GDP) in constant prices is projected to grow 7.4 per cent in the current financial year, against 6.5 per cent in 2024-25.

Emcure sets sights on pan-Indian obesity market with Poviztra

Emcure sets sights on pan-Indian obesity market with Poviztra

Rediff.com23 Dec 2025

Emcure Pharmaceuticals on Monday said it saw Poviztra, its newly launched semaglutide brand, as a "long-term" opportunity in India's fast-evolving obesity and cardiometabolic therapy market, even as price competition in the glucagon-like peptide-1 (GLP-1) segment intensified.

Kingpin in Rs 252-cr meow-meow haul nabbed after Dubai deportation

Kingpin in Rs 252-cr meow-meow haul nabbed after Dubai deportation

Rediff.com23 Oct 2025

Mumbai police have arrested Mohammed Salim Mohammed Suhail Shaikh, a key accused in a Rs 252-crore mephedrone seizure case, after his deportation from Dubai. Shaikh, known as 'Lavish,' is a member of an international drug syndicate and managed the supply and distribution chain from Dubai.

Why US attacked Venezuela and captured Maduro

Why US attacked Venezuela and captured Maduro

Rediff.com4 Jan 2026

The US government, under President Trump, justifies the intervention as a security necessity rather than a resource grab. The primary official reasons include: narco-terrorism charges, national security and migration crisis.

Some naturalised Americans likely to lose citizenship

Some naturalised Americans likely to lose citizenship

Rediff.com19 Dec 2025

The Trump administration is looking at plans to strip some naturalised Americans of their citizenship, the latest in a series of efforts undertaken by President Donald Trump to crack down on immigration.

Centre Moves To Bar Drugmakers Over Fake Information

Centre Moves To Bar Drugmakers Over Fake Information

Rediff.com3 Nov 2025

At present, there is no provision under Drugs Rules, 1945 to address issues of wrong information to obtain regulatory approvals.

After Srikanth, actor Krishna held in Chennai drug trafficking case

After Srikanth, actor Krishna held in Chennai drug trafficking case

Rediff.com27 Jun 2025

This follows an earlier incident on May 22, 2025, in which a large quantity of drugs was seized near the Nungambakkam railway station, according to a Greater Chennai Police press release.

Trump's 100% tariff on pharma unlikely to hurt domestic industry: Experts

Trump's 100% tariff on pharma unlikely to hurt domestic industry: Experts

Rediff.com26 Sep 2025

Indian Pharmaceutical Alliance (IPA) on Friday said US President Donald Trump's move to impose 100 per cent import tariffs on pharmaceutical drugs from October 1 will impact only patented and branded products, not generic medicines.

Cough syrup deaths: IMA slams doctor's arrest

Cough syrup deaths: IMA slams doctor's arrest

Rediff.com7 Oct 2025

The Indian Medical Association (IMA) has defended a doctor arrested in connection with cough syrup deaths in Madhya Pradesh, attributing the incident to failures in the drugs regulatory system.

US tariffs: Only Sun Pharma exposed to some headline risk

US tariffs: Only Sun Pharma exposed to some headline risk

Rediff.com28 Sep 2025

The imposition of a 100 per cent tariff by the US on imports of branded and patented pharmaceutical products starting October 1 may not significantly hurt Indian drug makers, with Sun Pharma being exposed to some headline risk but with limited earnings impact, according to analysts. Among Indian companies, only Sun Pharma has sizeable sales from patented drugs in the US (about 17 per cent of 2024-25 revenue), HSBC Global Investment Research said in a report.

Cough syrup deaths: Pharma co to face criminal action

Cough syrup deaths: Pharma co to face criminal action

Rediff.com8 Oct 2025

Tamil Nadu Government will take criminal action against a drug manufacturer, whose cough syrup has been banned in the wake of children's deaths in Madhya Pradesh, state minister Ma Subramanian said here on Wednesday.

Cough syrup kills 14 children in MP, doctor arrested

Cough syrup kills 14 children in MP, doctor arrested

Rediff.com5 Oct 2025

Police have arrested a doctor for alleged negligence and registered a case against the manufacturer of a 'toxic' cough syrup after the death of 14 children in Chhindwara due to suspected renal failure, officials said on Sunday.

Deadly cough syrup toll rises to 20 in MP; Kerala bans Sresan medicines

Deadly cough syrup toll rises to 20 in MP; Kerala bans Sresan medicines

Rediff.com8 Oct 2025

Madhya Pradesh Deputy Chief Minister Rajendra Shukla confirmed that 20 children have died after consuming contaminated cough syrup. An investigation is underway, and action has been taken against the manufacturer, doctor, and FDA officials.

Tylenol row may not hit India's pharma exports

Tylenol row may not hit India's pharma exports

Rediff.com29 Sep 2025

Amid controversy over USPresident Donald Trump's comments linking the use of Tylenol and other related paracetamol products by pregnant women to autism in children, experts and industry executives say that since India's export of the drug to the US is less, it will hardly affect the country's pharma exports to America.

Rajasthan govt bans cough syrup after children's deaths

Rajasthan govt bans cough syrup after children's deaths

Rediff.com2 Oct 2025

A generic cough syrup supplied to the Rajasthan government has been linked to the deaths of two children and others falling sick in the state, prompting authorities to ban 22 batches of the drug and order an inquiry.

TN, MP ban Coldrif cough syrup after child deaths

TN, MP ban Coldrif cough syrup after child deaths

Rediff.com4 Oct 2025

The toll in the case reached nine in Madhya Pradesh while media reports said of two infants died in Rajasthan.

Cough syrup deaths: Many states ban Coldrif; MP suspends officials

Cough syrup deaths: Many states ban Coldrif; MP suspends officials

Rediff.com7 Oct 2025

A special investigation team (SIT) has been formed in Madhya Pradesh to investigate the deaths of 14 children in Chhindwara, suspected to be linked to a toxic cough syrup. The investigation includes arrests, exhumations, and a ban on the implicated cough syrup.

Generic industry unlikely to be affected by Trump's EO: Indian drug cos

Generic industry unlikely to be affected by Trump's EO: Indian drug cos

Rediff.com14 May 2025

A fresh US executive order (EO) which seeks to bring down prices of prescription drugs in the country by up to 90 per cent -- on par with other developed nations -- will affect innovator companies, while sparing the Indian generic drug makers in the short term. US President Donald Trump signed the EO on Monday, directing the US Trade Representative and the Secretary of Commerce to act against foreign countries that "purposefully and unfairly undercut market prices", driving price hikes in the US.